|
|
||||||||
Guest Access | Sign In via User Name/Password |
|||||||||
1 From the Division of Pulmonary and Critical Care Medicine, UMDNJ/Robert Wood Johnson Medical School at Camden, Camden NJ.
Asthma is a common disease for which morbidity and mortality have been increasing. This despite advances in the scientific understanding of asthma and in the pharmacologic armamentarium available to treat it. The dichotomy between knowledge and outcomes led us to review asthma from a systems perspective. We have presented data first to document failure in the current system of care and then to examine factors associated with improved outcomes. We found a disparity in outcome and costs when care given by experts was contrasted with care given by generalists. We conclude that "expert-based" care systems are superior from the perspective both of the patient and of the insurer; medical outcomes are better at lower overall cost. Managed care companies are in a unique position to identify asthmatics and to shift them from generalist to expert-based care when appropriate.
Key Words: asthma clinical outcomes expert care managed care
Submitted on January 16, 1996
Accepted on July 24, 2007
This article has been cited by other articles:
![]() |
M. FitzGerald Extracts from ""Clinical Evidence"": Acute asthma BMJ, October 13, 2001; 323(7317): 841 - 845. [Full Text] [PDF] |
||||
![]() |
W. J. CALHOUN, H. S. NELSON, R. A. NATHAN, P. J. PEPSIN, C. KALBERG, A. EMMETT, K. A. RICKARD, and P. DORINSKY Comparison of Fluticasone Propionate-Salmeterol Combination Therapy and Montelukast in Patients Who Are Symptomatic on Short-acting beta 2-Agonists Alone Am. J. Respir. Crit. Care Med., September 1, 2001; 164(5): 759 - 763. [Abstract] [Full Text] [PDF] |
||||
![]() |
Asthma education and patient monitoring Can. Med. Assoc. J., November 1, 1999; 161(90111): s15 - 19. [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |